These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3311040)

  • 1. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. III. Generation of monoclonal antibody specific for human MIF.
    Fahlbusch B; Schumann I
    Biomed Biochim Acta; 1987; 46(5):397-406. PubMed ID: 3311040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. II. Production and characterization of an anti-MIF antibody.
    Fahlbusch B; Metzner G; Schumann I; Tittel R
    Biomed Biochim Acta; 1986; 45(3):371-84. PubMed ID: 3518711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. I. Biochemical characterization and purification.
    Fahlbusch B; Tittel R
    Biomed Biochim Acta; 1986; 45(3):359-70. PubMed ID: 3518710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor (MIF) produced by a human T cell hybridoma clone.
    Oki S; Hirose S; Higuchi M; Osawa T
    Lymphokine Cytokine Res; 1991 Aug; 10(4):273-80. PubMed ID: 1932371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
    Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
    Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody against migration inhibitory factor (MIF) obtained by immunization with MIF from the human lymphoblast cell line Mo.
    Kawaguchi T; Mednis A; Golde DW; David JR; Remold HR
    J Leukoc Biol; 1986 Feb; 39(2):223-32. PubMed ID: 3079811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody against human interleukin 2 (IL 2). I. Purification of IL 2 for the production of monoclonal antibodies.
    Stadler BM; Berenstein EH; Siraganian RP; Oppenheim JJ
    J Immunol; 1982 Apr; 128(4):1620-4. PubMed ID: 6977565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on guinea-pig macrophage migration inhibitory factor (MIF). I. Glycoprotein nature and net charge.
    Kotkes P; Pick E
    Clin Exp Immunol; 1979 Sep; 37(3):532-9. PubMed ID: 228883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine monoclonal antibodies directed against human recombinant Macrophage Migration Inhibitory Factor.
    Rupreht RR; Moyetic B; Franckz A; Matis M; Skoberne M; Galvani V; Malovrh T; Kotnik V; Curin Serbec V
    Pflugers Arch; 2000; 440(5 Suppl):R78-80. PubMed ID: 11005620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of a monoclonal antibody (1C5) to human migration inhibitory factor (MIF).
    Burmeister G; Tarcsay L; Sorg C
    Immunobiology; 1986 Jul; 171(4-5):461-74. PubMed ID: 3527953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of antigen-dependent macrophage migration inhibition factor (MIF) from lymph draining a tuberculin reaction.
    Scott DM; McConnell I; Agomo P; Lachmann PJ
    Immunology; 1978 Apr; 34(4):591-604. PubMed ID: 363599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of human hybridomas producing migration inhibitory factor (MIF) and of murine hybridomas secreting monoclonal antibodies to human MIF.
    Weiser WY; Remold HG; David JR
    Cell Immunol; 1985 Jan; 90(1):167-78. PubMed ID: 3881187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody.
    Thurman GB; Braude IA; Gray PW; Oldham RK; Stevenson HC
    J Immunol; 1985 Jan; 134(1):305-9. PubMed ID: 3917277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis.
    Sakai Y; Masamune A; Satoh A; Nishihira J; Yamagiwa T; Shimosegawa T
    Gastroenterology; 2003 Mar; 124(3):725-36. PubMed ID: 12612911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nonspecific inhibitor of macrophage migration in cell-free ascites of rat Zajdela hepatoma. II. Biochemical characterization and purificaton.
    Fahlbusch B; Zschiesche W
    Acta Biol Med Ger; 1981; 40(6):793-800. PubMed ID: 7034428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy.
    Leung JC; Chan LY; Tsang AW; Liu EW; Lam MF; Tang SC; Lai KN
    Nephrol Dial Transplant; 2004 Aug; 19(8):1976-85. PubMed ID: 15187193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to human procoagulant factor VIII.
    Rotblat F; Goodall AH; O'Brien DP; Rawlings E; Middleton S; Tuddenham EG
    J Lab Clin Med; 1983 May; 101(5):736-46. PubMed ID: 6403638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monoclonal antibody specific for a monocyte-macrophage membrane component blocks the human monocyte response to migration inhibitory factor.
    Liu DY; Todd RF
    J Immunol; 1986 Jul; 137(2):448-55. PubMed ID: 3522731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
    Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New monoclonal antibodies directed against human renin. Powerful tools for the investigation of the renin system.
    Galen FX; Devaux C; Atlas S; Guyenne T; Menard J; Corvol P; Simon D; Cazaubon C; Richer P; Badouaille G
    J Clin Invest; 1984 Sep; 74(3):723-35. PubMed ID: 6381539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.